Literature DB >> 23678556

Assessment of biofilm by nasal cytology in different forms of rhinitis and its functional correlations.

M Gelardi1, G Passalacqua, M L Fiorella, N Quaranta.   

Abstract

BACKGROUND: Recently, it has been reported that nasal cytology in light microscopy can identify biofilms, which appear as cyan-stained "Infectious Spots". We assessed by the same method and in the same population, the presence of biofilms in different nasal disorders, and estimated if a correlation with the functional grade of obstruction existed.
METHODS: Subjects suffering from different nasal disorders, after a detailed clinical history and ENT examination, underwent nasal fibroendoscopy, skin prick test, rhinomanometry and nasal cytology. The presence of biofilm was linked to the type ofdisease and to the grade of obstruction.
RESULTS: Among 1,410 subjects previously studied, the infectious spot was found in 107 patients (7.6%), and this percentage reached 55.4% in subjects with cytologic signs of infectious rhinitis (presence of bacteria/fungi). Biofilms were largely more frequent in patients with adenoid hypertrophy (57.4%), followed by nasal polyposis (24%), chronic rhinosinusitis (9.5%) and non-allergic rhinitis (7.6%). Nasal cytology was normal in the remaining patients, where no infectious spot was detectable. Statistical analysis showed that nasal resistances were significantly higher in presence of biofilms in patients with adenoid hypertrophy (p = 0.003), nasal polyposis (p < 0.001), chronic rhinosinusitis (p = 0.018) and septal deviation (p = 0.001).
CONCLUSION: The results demonstrate that biofilm is present not only in infectious rhinitis, but also in inflammatory and/or immune-mediated diseases. The presence of biofilms significantly correlates with the degree of nasal obstruction as assessed by rhinomanometry.

Entities:  

Mesh:

Year:  2013        PMID: 23678556

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  7 in total

Review 1.  Fungi in the Wound Microbiome.

Authors:  Lindsay Kalan; Elizabeth A Grice
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

2.  Polyhexanide-containing solution reduces ciliary beat frequency of human nasal epithelial cells in vitro.

Authors:  Richard Birk; C Aderhold; J Stern-Sträter; K Hörmann; B A Stuck; J U Sommer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-06       Impact factor: 2.503

3.  Colonisation and interaction between S. epidermidis and S. aureus in the nose and throat of healthy adolescents.

Authors:  E G A Fredheim; T Flægstad; F Askarian; C Klingenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-01       Impact factor: 3.267

Review 4.  Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management.

Authors:  Dimitri Poddighe; Matteo Gelardi; Amelia Licari; Michele Miraglia Del Giudice; Gian Luigi Marseglia
Journal:  World J Methodol       Date:  2016-12-26

5.  Determinants of chronic otitis media with effusion in preschool children: a case-control study.

Authors:  Rebecca E Walker; Jim Bartley; David Flint; John M D Thompson; Edwin A Mitchell
Journal:  BMC Pediatr       Date:  2017-01-06       Impact factor: 2.125

6.  Effects of tranexamic acid on human nasal ciliary beat frequency.

Authors:  W Behr; F Horschke; A Nastev; C E Mueller; J U Sommer; B Folz; H Li; U W Geisthoff; B A Stuck; R Birk
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-04       Impact factor: 2.503

Review 7.  Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021.

Authors:  Chengshuo Wang; Lei Cheng; Huabin Li; Zheng Liu; Hongfei Lou; Jianbo Shi; Ying Sun; Dehui Wang; Qintai Yang; Hongmeng Yu; Changqing Zhao; Dongdong Zhu; Fengli Cheng; Yan Li; Bo Liao; Meiping Lu; Cuida Meng; Shen Shen; Yueqi Sun; Rui Zheng; Luo Zhang
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.